The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Droopy Eyelid
- Glaucoma
- Glaucoma Open-Angle
- Glaucoma Primary Open Angle
- Glaucoma; Drugs
- Ptosis
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Each patient will be randomized to receive the study medication in one eye and placebo in the other eye.Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04007276
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Ze Zhang, MD Tulane University